首页> 外文期刊>Clinical immunology: The official journal of the Clinical Immunology Society >Analysis of human sera that are polyreactive in an addressable laser bead immunoassay.
【24h】

Analysis of human sera that are polyreactive in an addressable laser bead immunoassay.

机译:在可寻址的激光珠免疫测定中分析具有多反应性的人血清。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Following the introduction of addressable laser bead immunoassays (ALBIA) into our clinical laboratory, it was noted that certain sera would exhibit reactivity to numerous antigens in the array. To further understand the nature of this reactivity, we analyzed the reactivity of sequential sera that were identified over a 1 year period. METHODS: Sera that demonstrated reactivity to 6 or more of the 8 antigens in an ALBIA kit (QuantaPlex 8: chromatin, Sm, RNP, Scl-70, ribosomal P protein, SS-A/Ro, SS-B/La, Jo-1) were tested for autoantibodies by indirect immunofluorescence (IIF) on HEp-2 cell substrates, for IgG, IgM and IgA rheumatoid factor, chromatin and ribosomal P protein by ELISA and by LINE immunoassay (LIA) and immunoblotting (IB). RESULTS: In one calendar year, 40/4096 (0.8%) sera analyzed in a routine clinical laboratory setting demonstrated reactivity to 6 or more antigens in the QuantaPlex 8 kits. There was no common IIF pattern that could be attributed to the polyreactive sera. There was no apparent correlation of polyreactivity with IIF titers, indeed, 4/40 (10%) sera had a negative ANA at the screening dilution of 1/160. When subjected to IB, LIA and ELISA, polyreactivity to three or more antigens was confirmed for 12/40 (30%) of sera while 8/40 (20%) had reactivity to 1-2 antigens and 20 (50%) did not react with any antigens in these assays. Overall agreement of positive or negative tests between the ALBIA and IB, LIA and ELISA was 75% for chromatin, 50% for SS-A, 27.5% for Sm, 25% for Rib-P, 22.5% for RNP, 20% for Scl-70, 15% for Jo-1 and 7.5% for SS-B. 17/40 (42.5%) had a positive IgM, IgG or IgA rheumatoid factor, and 12/40 (30%) had all three isotype rheumatoid factors. CONCLUSIONS: On average, the agreement between ALBIA and other assays in this study of polyreactive sera was 30%. Approximately, one-half of sera that demonstrate reactivity to multiple autoantigens in a commercial ALBIA were confirmed to have reactivity to at least one autoantigen in another diagnostic assay and 30% could be regarded as polyreactive. Other sera, some of which had rheumatoid factor, appeared to have high background binding without demonstrating specific binding to any of the cognate antigens.
机译:背景:在我们的临床实验室中引入可寻址激光珠免疫测定(ALBIA)之后,注意到某些血清对阵列中的多种抗原具有反应性。为了进一步了解这种反应性的本质,我们分析了在1年内鉴定出的连续血清的反应性。方法:血清对ALBIA试剂盒中的8种抗原中的6种或更多种具有反应性(QuantaPlex 8:染色质,Sm,RNP,Scl-70,核糖体P蛋白,SS-A / Ro,SS-B / La,Jo- 1)通过间接免疫荧光(IIF)在HEp-2细胞底物上检测自身抗体,通过ELISA和LINE免疫测定(LIA)和免疫印迹(IB)检测IgG,IgM和IgA类风湿因子,染色质和核糖体P蛋白。结果:在一日历年中,在常规临床实验室环境中分析的40/4096(0.8%)血清在QuantaPlex 8试剂盒中显示出对6种或更多种抗原的反应性。没有常见的IIF模式可归因于多反应性血清。多反应性与IIF滴度没有明显的相关性,实际上,在1/160的筛选稀释度下,4/40(10%)血清的ANA阴性。当进行IB,LIA和ELISA检验时,证实12/40(30%)血清对三种或更多种抗原具有多反应性,而8/40(20%)对1-2种抗原具有反应性而20(50%)对三种抗原无反应性在这些测定中与任何抗原发生反应。 ALBIA与IB,LIA和ELISA之间阳性或阴性测试的总体一致性为染色质75%,SS-A 50%,Sm 27.5%,Rib-P 25%,RNP 22.5%,Scl 20% -70,Jo-1为15%,SS-B为7.5%。 17/40(42.5%)的IgM,IgG或IgA类风湿因子阳性,而12/40(30%)的所有三种同种型类风湿因子阳性。结论:在这项多反应性血清研究中,ALBIA与其他检测方法之间的一致性平均为30%。大约有一半的血清在商业ALBIA中显示出对多种自身抗原的反应性,在另一种诊断测定中被证实与至少一种自身抗原具有反应性,其中30%的血清被认为是多反应性的。其他血清,其中一些具有类风湿因子,似乎具有很高的背景结合能力,而没有表现出与任何同类抗原的特异性结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号